Multiple missense mutations of human CIB2 or TMC-1 are associated with non-syndromic hearing loss by either impeding the interaction between TMC-1 and CIB2 or by reducing the Ca2+ binding propensity of CIB214. This evidence concerns the gene CIB2 and hearing loss disorder.